Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing

Funds to support the first-in-human clinical study of the company’s SirPlux™ Duo Drug-Coated Balloon for the treatment of de-novo coronary artery disease LOS GATOS, Calif., June 28, 2022 /PRNewswire/ — Advanced NanoTherapies, Inc., a privately-held medical device company committed to…

About the Author

has written 39663 stories on this site.

Copyright © 2010 Business and Corporate News.